Detecting multiple autoantibodies to diagnose autoimmune co-morbidity (multiple autoimmune syndromes and overlap syndromes): A challenge for the autoimmunologist

Immunologic Research

Volumn 56, Issue 2-3, 2013, Pages 425-431

  Tozzoli, Renato ^a   Sorrentino, Maria Concetta ^b   Bizzaro, Nicola ^c  

^a S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^b Mediterranean Institute for Transplantation and Advanced Specialized Therapies   (Italy)

^c San Antonio Hospital   (Italy)

Author keywords

Autoimmune liver diseases; Autoimmunology; Co morbidity; Connective tissue diseases; Multiple autoimmune syndromes; Overlap syndromes; Polyautoimmunity

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; INTRINSIC FACTOR; PARIETAL CELL ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; RHEUMATOID FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADDISON DISEASE; ADRENAL CORTEX; ANTIBODY DETECTION; ARTICLE; ATROPHIC GASTRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; AUTOIMMUNE LIVER DISEASE; AUTOIMMUNITY; COMORBIDITY; DISEASE ASSOCIATION; EPIDEMIOLOGY; GENERAL CONDITION; HUMAN; HYPOPARATHYROIDISM; HYPOPHYSIS; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY PERSONNEL; MITOCHONDRION; MIXED CONNECTIVE TISSUE DISEASE; MUCOCUTANEOUS CANDIDIASIS; PERNICIOUS ANEMIA; POLYMYOSITIS; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THYROID DISEASE; VITILIGO;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CLUSTER ANALYSIS; COMORBIDITY; HUMANS; INTERDISCIPLINARY COMMUNICATION; ITALY; PRACTICE GUIDELINES AS TOPIC; SEROLOGIC TESTS;

EID: 84879556321     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-013-8418-7     Document Type: Article

References (41)

1. Eaton WW, Pedersen MG, Atladottir HO, Gregory PE, Rose NR, Mortensen PB. The prevalence of 30 ICD-10 autoimmune diseases in Denmark. Immunol Res. 2010;47:228-31.
2. Selmi C. The worldwide gradient of autoimmune conditions. Autoimmun Rev. 2010;9:A247-50.
3. Sardu C, Cocco E, Mereu A, Massa R, Cuccu A, Marrosu MG, et al. Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity. PLoS ONE. 2012;7:e32487.
4. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997;84:223-43. (Pubitemid 27398022)
5. Walsh SJ, Rau LM. Autoimmune disease: a leading cause of death among young and middle-aged women in the United States. Am J Public Health. 2000;90:1463-6.
6. Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB. Epidemiology of autoimmune diseases in Denmark. J Autoimmun. 2007;29:1-9. (Pubitemid 47016917)
7. Cooper GS, Bynum MLK, Somers EC. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun. 2009;33:197-207.
8. Tozzoli R, Bizzaro N. The clinical autoimmunologist and the laboratory autoimmunologist: the two sides of the coin. Autoimmun Rev. 2012;11:766-70.
9. Hayter SM, Cook MC. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev. 2012;11:754-65.
10. Rojas-Villarraga A, Amaya-Amaya J, Rodriguez-Rodriguez A, Mantilla RD, Anaya J-M. Introducing polyautoimmunity: secondary autoimmune diseases no longer exist. Autoimmun Dis. 2012;2012:254319.
11. Betterle C, Presotto F. Autoimmune polyendocrine syndromes (APS) or multiple autoimmune syndromes (MAS). In: Jara LJ, Walker SE, editors. Handbook of systemic autoimmune disease. Endocrine manifestations of systemic autoimmune diseases. Amsterdam: Elsevier; 2008. p. 135-48.
12. Agmon-Levin N, Lian Z, Shoenfeld Y. Explosion of autoimmune diseases and the mosaic of old and novel factors. Cell Moll Immunol. 2011;8:188-92.
13. Neufeld M, Blizzard RM. Polyglandular autoimmune diseases. In: Pinchera A, Doniach D, Fenzi GF, Baschieri L, editors. Symposium on autoimmune aspects of thyroid disorders. New York: Academic Press; 1980. p. 357-65.
14. Betterle C, Zanchetta R. Update on autoimmune polyendocrine syndromes (APS). Acta Bio Medica. 2003;74:9-33. (Pubitemid 36850394)
15. Weetman AP. Non-thyroid autoantibodies in autoimmune thyroid disease. Best Pract Res Clin Endocrinol Metab. 2005;19:17-32. (Pubitemid 40253947)
16. Weetman AP. Diseases associated with thyroid autoimmunity: explanations for the expanding spectrum. Clin Endocrinol. 2011;74:411-8.
17. Tozzoli R, Kodermaz G, Perosa AR, Tampoia M, Zucano A, Antico A, et al. The predictive role of parietal cell autoantibodies for atropic gastritis: a prospective five-year follow-up study in patients with autoimmune thyroid diseases. Autoimmun Rev. 2010;10:80-3.
18. Iaccarino L, Gatto M, Bettio S, Caso F, Rampudda M, Zen M, et al. Overlap connective tissue disease syndromes. Autoimmun Rev. 2013;12:363-73.
19. Czaja AJ. The overlap syndromes of autoimmune hepatitis. Dig Dis Sci 2012 (Epub ahead of print).
20. Rekvig OP, Putterman C, Casu C, Gao HX, Ghirardello A, Mortensen ES, et al. Autoantibodies in lupus: culprits or passive bystanders? Autoimmun Rev. 2012;11:596-603.
21. Agmon-Levin N, Mosca M, Petri M, Shoenfeld Y. Systemic lupus erythematosus one disease or many? Autoimmun Rev. 2012;11:593-5.
22. Bellando Randone S, Martinović D, Tamas MM, Pasalić K, Allanore Y, et al. To be or not to be, ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum. 2012;41:589-98.
23. Hutfless S, Matos P, Talor MV, Caturegli P, Rose NR. Significance of prediagnostic thyroid antibodies in women with autoimmune thyroid disease. J Clin Endocrinol Metab. 2011;96:E1466-71.
24. Efe C, Wahlin S, Ozaslan E, Berlot AH, Purnak T, Muratori L, et al. Autoimmune hepatitis/primary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. Eur J Gastroenterol Hepatol. 2012;24:531-4.
25. Teufel A, Weinmann A, Kahaly GJ, Centner C, Piendl A, Worns M, et al. Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol. 2010;44:208-13.
26. Silveira MG, Mendes FD, Diehl NN, et al. Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver diseases. Liver Int. 2009;29:1094-100.
27. Rust C, Beuers U. Overlap syndromes among autoimmune liver diseases. World J Gastroenterol. 2008;14:3368-73.
28. Gheorghe L, Iacob S, Gheorghe C, et al. Frequency and predictive factors for overlap between autoimmune hepatitis and primary biliary cirrhosis overlap syndrome. Eur J Gastroenterol Hepatol. 2004;16:585-92. (Pubitemid 38703867)
29. Zhao P, Han Y. Low incidence of positive smooth muscle antibody and high incidence of isolated IgM elevation in Chinese patients with autoimmune hepatitis and primary biliary cirrhosis overlap syndrome: a retrospective study. BMC Gastroenterol. 2012;12:1.
30. Floreani A, Rizzotto ER, Ferrara F, et al. Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. Am J Gastroenterol. 2005;100:1516-22. (Pubitemid 41032356)
31. Hunter M, Loughrey MB, Gray M, et al. Evaluating distinctive features for early diagnosis of primary sclerosing cholangitis overlap syndrome in adults with autoimmune hepatitis. Ulster Med J. 2011;80:15-8.
32. Muratori P, Granito A, Pappas G, Pendino GM, Quarneti C, Cicola R, et al. The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Am J Gastroenterol. 2009;104:1420-5.
33. Burak KW, Urbanski SJ, Swain MG. A case of coexisting primary biliary cirrhosis and primary sclerosing cholangitis: a new overlap of autoimmune liver disease. Dig Dis Sci. 2001;46:2043-7. (Pubitemid 32844175)
34. Bizzaro N, Tozzoli R, Shoenfeld Y. Are we at a stage to predict autoimmune rheumatic diseases? Arthritis Rheum. 2007;56:1736-44. (Pubitemid 47110373)
35. Bidoli E, Villalta D. Epidemiological and ethical aspects of multiplex autoantibody testing. Autoimmun Rev. 2007;6:354-8. (Pubitemid 46810404)
36. Fritzler MJ. Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes. Autoimmun Rev. 2008;7:616-20.
37. Bizzaro N. Autoantibodies as predictors of disease: the clinical and experimental evidence. Autoimmun Rev. 2007;6:325-33. (Pubitemid 46810400)
38. Tozzoli R. The diagnostic role of autoantibodies in the prediction of organ-specific autoimmune diseases. Clin Chem Lab Med. 2008;46:577-87. (Pubitemid 351749117)
39. Tozzoli R, Bonaguri C, Melegari A, Antico A, Bassetti D, Bizzaro N. Current state of diagnostic technologies in the autoimmunology laboratory. Clin Chem Lab Med. 2013;51:129-38.
40. Barabas AZ, Cole CD, Graeff RM, Lafreniere R, Weir DM. The role of autoimmunologists in investigating and treating autoimmune disorders. Autoimmun Rev. 2012;10:166-70.
41. Shoenfeld Y, Selmi C, Zimlichman E, et al. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time of autoimmunity. J Autoimmun. 2008;31:325-30.